OnCusp Therapeutics

About:

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

Website: https://www.oncusptx.com

Top Investors: OrbiMed, F-Prime Capital, Marshall Wace, Novo Holdings, Sofinnova Investments

Description:

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments. It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancer patients around the world. It is founded by Bing Yuan, Eric Slosberg, and Andy Fu.